Skip to content

Effects of Local Anesthesia on Post-operative Pain During Laparoscopic Inguinal Hernia Repair

A Randomized, Double-blinded, Placebo-controlled Trial of the Effects of Infusing Local Anesthesia on Post-operative Pain During Laparoscopic Inguinal Hernia Repair

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02055053
Enrollment
70
Registered
2014-02-04
Start date
2013-08-31
Completion date
2019-10-16
Last updated
2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post Operative Pain (Post Laparoscopic Hernia Repair)

Keywords

Post Operative Pain, hernia repair

Brief summary

To assess effect of local anesthetic into the preperitoneal space during laparoscopic hernia repair on post-operative pain.

Interventions

DRUG0.5% Bupivicaine

Local anesthetic

Sponsors

Lahey Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18 or older with unilateral or bilateral inguinal herna for laparoscopic repair * American Society of Anesthesiology (ASA) Class I and II

Exclusion criteria

* Conversion from laparoscopic to open surgery * History of Chronic pain or ongoing treatment for chronic pain * Age less than 18 yrs * Allergy to local anesthetics

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale Pain Score Assessment (VAS)Post-operative periodPain level at 4 hours after surgery VAS scale measures pain in whole numbers from 0 (no pain) to 10 (worst imaginable pain)

Secondary

MeasureTime frameDescription
Amount of Pain Medication Used in Oral Morphine Equivalents4 hours after surgeryTotal mg of opiate after surgery
Duration of Narcotic Used to Control Pain4 weeks post-opNumber of days post-operatively narcotic is used

Countries

United States

Participant flow

Participants by arm

ArmCount
Anesthetic Intervention
After deployment of therapeutic mesh in the preperitoneal space of the abdomen wall during the procedure, the treatment group will receive infusion of 15 cc 0.5% Bupivicaine. 0.5% Bupivicaine: Local anesthetic
35
Saline Intervention
After deployment of therapeutic mesh in the preperitoneal space of the abdomen wall during the procedure, the placebo group will receive the infusion of 15 cc 0.9% Saline. 0.5% Bupivicaine: Local anesthetic
35
Total70

Baseline characteristics

CharacteristicAnesthetic InterventionSaline InterventionTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
5 Participants5 Participants10 Participants
Age, Categorical
Between 18 and 65 years
30 Participants30 Participants60 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
35 Participants35 Participants70 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
United States
35 participants35 participants70 participants
Sex: Female, Male
Female
33 Participants34 Participants67 Participants
Sex: Female, Male
Male
2 Participants1 Participants3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 350 / 35
other
Total, other adverse events
0 / 350 / 35
serious
Total, serious adverse events
0 / 350 / 35

Outcome results

Primary

Visual Analog Scale Pain Score Assessment (VAS)

Pain level at 4 hours after surgery VAS scale measures pain in whole numbers from 0 (no pain) to 10 (worst imaginable pain)

Time frame: Post-operative period

ArmMeasureValue (MEAN)Dispersion
Anesthetic InterventionVisual Analog Scale Pain Score Assessment (VAS)2.96 score on a scaleStandard Deviation 2.3
Saline InterventionVisual Analog Scale Pain Score Assessment (VAS)3.24 score on a scaleStandard Deviation 1.57
Primary

Visual Analog Scale Pain Score Assessment (VAS)

Pain level recorded at 3 days after surgery. VAS scale measures pain in increments of whole numbers from 0 (no pain) to 10 (most sever pain imaginable)

Time frame: Pain scale 3 days after surgery

ArmMeasureValue (MEAN)Dispersion
Anesthetic InterventionVisual Analog Scale Pain Score Assessment (VAS)3.71 units on a scaleStandard Deviation 2.08
Saline InterventionVisual Analog Scale Pain Score Assessment (VAS)3.25 units on a scaleStandard Deviation 1.66
Secondary

Amount of Pain Medication Used in Oral Morphine Equivalents

Total mg of opiate after surgery

Time frame: 4 hours after surgery

Population: one patient's data is missing

ArmMeasureValue (MEAN)Dispersion
Anesthetic InterventionAmount of Pain Medication Used in Oral Morphine Equivalents8.37 oral morphine equivalentsStandard Deviation 12.18
Saline InterventionAmount of Pain Medication Used in Oral Morphine Equivalents7.72 oral morphine equivalentsStandard Deviation 10.23
Secondary

Duration of Narcotic Used to Control Pain

Number of days post-operatively narcotic is used

Time frame: 4 weeks post-op

Population: Data were not collected for any patients.

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026